View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
The global market for breast lesion localization devices is set for substantial growth, with sales estimated to reach USD 360.9 million in 2024 and expected to climb to USD 593.5 million by 2034. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results